U.S. buys up worldwide stock of remdesivir, drug seen as potential COVID-19 treatment - 2020-06-30

From UmbraXenu
Jump to: navigation, search
F0.png U.S. buys up worldwide stock of remdesivir, drug seen as potential COVID-19 treatment June 30, 2020, Sean Boynton, Global News

The United States has secured nearly the entire worldwide supply of remdesivir, a drug that's proven effective for severely ill patients of the novel coronavirus — leaving hardly any for Canada and the rest of the world.

The Department of Health and Human Services (HHS) announced Monday it has secured more than 500,000 treatment courses of the drug from its sole manufacturer Gilead Sciences for American hospitals through September. Each treatment course uses an average of over six vials of the drug.

According to a news release, the buyout represents 100 per cent of Gilead's projected production for July, 90 per cent of August's production, and 90 per cent of production through September. A further "allocation for clinical trials" has also been secured.

Wikipedia cite:
{{cite news | first = Sean | last = Boynton | title = U.S. buys up worldwide stock of remdesivir, drug seen as potential COVID-19 treatment | url = https://globalnews.ca/news/7127951/us-remdesivir-supply-coronavirus/ | work = Global News | date = June 30, 2020 | accessdate = July 1, 2020 }}